Market Overview

Morgan Stanley: 'Future Looks Bright' At Anthem

Fast Money Traders Share Their Picks In Health Care Space
Jim Cramer Weighs In On Nucor, CIGNA, Advanced Micro Devices And Viacom
Related HUM
A Look At Nvidia's Largest Shareholders And What Their Presence Means
Watch These 5 Huge Call Purchases In Friday Trade
Where Is The Democrats' Plan To Fix ObamaCare? (Investor's Business Daily)

In a report published Thursday, Morgan Stanley analysts maintained an Equal-Weight rating on Anthem Inc (NYSE: ANTM), with a price target of $155, after the company reported its 1Q results significantly ahead of expectations.

Anthem reported its 1Q EPS at ~$0.50, ahead of consensus estimates, driven by commercial performance. The aggregate MLR declined 250bps Y/Y mainly on account of lower medical costs in the Local Group and individual businesses.

In the report Morgan Stanley noted, "Enrollment was also higher-than-expected in the quarter driven primarily by increases in self-funded membership."

Anthem raised its revenue and EPS outlook for FY15 to ~$78.5B and >$9.90, respectively. "Management also mentioned positive trends into 2016 including an expectation for improved Medicare performance, two large National Account wins, and lower ACA headwinds," the analysts said, while adding that the outlook revision looks "conservative to us."

The EPS and revenue estimates for 2015 have been raised to $10.10 and ~$78.5, respectively, after after the strong start to the year and to reflect higher self-funded membership. The EPS estimate for 2016 has been raised to $11.30.

The analysts believe that the issues highlighted by Humana Inc
(NYSE: HUM) are company-specific and should not impact Anthem.

Latest Ratings for ANTM

Apr 2017Cantor FitzgeraldUpgradesHoldOverweight
Apr 2017Deutsche BankInitiates Coverage OnHold
Jan 2017PiperJaffrayInitiates Coverage OnNeutral

View More Analyst Ratings for ANTM
View the Latest Analyst Ratings

Posted-In: Morgan Stanley VetrAnalyst Color Reiteration Analyst Ratings


Related Articles (HUM + ANTM)

View Comments and Join the Discussion!